These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 34343739)

  • 1. Associations between osteoporosis and drug exposure: A post-marketing study of the World Health Organization pharmacovigilance database (VigiBase®).
    Batteux B; Bennis Y; Bodeau S; Masmoudi K; Hurtel-Lemaire AS; Kamel S; Gras-Champel V; Liabeuf S
    Bone; 2021 Dec; 153():116137. PubMed ID: 34343739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SGLT-2 inhibitors and ketoacidosis: a disproportionality analysis in the World Health Organization's adverse drug reactions database.
    Ado Moumouni AN; Robin P; Hillaire-Buys D; Faillie JL
    Fundam Clin Pharmacol; 2018 Apr; 32(2):216-226. PubMed ID: 29144574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase from 2010 to 2020.
    Ortland I; Mirjalili M; Kullak-Ublick GA; Peymani P
    Swiss Med Wkly; 2021 May; 151():w20503. PubMed ID: 34000058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incretin-based drugs and intestinal obstruction: A pharmacovigilance study.
    Gudin B; Ladhari C; Robin P; Laroche ML; Babai S; Hillaire-Buys D; Faillie JL
    Therapie; 2020; 75(6):641-647. PubMed ID: 32418731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thirst and drugs: A study in the World Health Organization's pharmacovigilance database.
    Montastruc JL
    Br J Clin Pharmacol; 2024 Jun; 90(6):1525-1528. PubMed ID: 38627211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal and Neonatal Adverse Drug Reactions Associated with Biologics Taken During Pregnancy by Women with Autoimmune Diseases: Insights from an Analysis of the World Health Organization Pharmacovigilance Database (VigiBase
    Dernoncourt A; Liabeuf S; Bennis Y; Masmoudi K; Bodeau S; Laville S; Hurtel-Lemaire AS; Gras-Champel V; Batteux B
    BioDrugs; 2023 Jan; 37(1):73-87. PubMed ID: 36401769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced vitiligo: a case/non-case study in Vigibase
    Anthony N; Bourneau-Martin D; Ghamrawi S; Lagarce L; Babin M; Briet M
    Fundam Clin Pharmacol; 2020 Dec; 34(6):736-742. PubMed ID: 32246859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitonin gene-related peptide antagonists in pregnancy: a disproportionality analysis in VigiBase
    Noseda R; Bedussi F; Gobbi C; Ceschi A; Zecca C
    J Headache Pain; 2024 Jan; 25(1):10. PubMed ID: 38243189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis.
    Hlavaty A; Roustit M; Montani D; Chaumais MC; Guignabert C; Humbert M; Cracowski JL; Khouri C
    Br J Clin Pharmacol; 2022 Dec; 88(12):5227-5237. PubMed ID: 35679331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database.
    Montastruc JL; Lafaurie M; de Canecaude C; Durrieu G; Sommet A; Montastruc F; Bagheri H
    Br J Clin Pharmacol; 2021 Nov; 87(11):4334-4340. PubMed ID: 33837554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive impairment associated with traditional and novel androgen receptor signaling inhibitors ± androgen deprivation therapy: a pharmacovigilance study.
    Briggs LG; Reese S; Herzog P; Nguyen DD; Labban M; Alkhatib K; Trinh QD; Morgans AK
    Prostate Cancer Prostatic Dis; 2023 Jun; 26(2):331-337. PubMed ID: 35436999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A replication study using the World Health Organization pharmacovigilance database (VigiBase®) to evaluate whether an association between ketamine and esketamine and alcohol and substance misuse exists.
    Kwan ATH; Rosenblat JD; Mansur RB; Rhee TG; Teopiz K; Le GH; Wong S; Cao B; Ho R; McIntyre RS
    J Affect Disord; 2024 Oct; 363():589-594. PubMed ID: 39029700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database.
    de Germay S; Montastruc F; Carvajal A; Lapeyre-Mestre M; Montastruc JL
    Parkinsonism Relat Disord; 2020 Jan; 70():55-59. PubMed ID: 31865063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Antiosteoporotic Drugs and Risk of Acute Kidney Injury: A Cross-Sectional Study Using Disproportional Analysis and a Pharmacovigilance Database.
    Mitsuboshi S; Kaseda R; Narita I
    J Clin Pharmacol; 2022 Nov; 62(11):1419-1425. PubMed ID: 35665942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disproportionality analysis in VigiBase as a drug repositioning method for the discovery of potentially useful drugs in Alzheimer's disease.
    Chrétien B; Jourdan JP; Davis A; Fedrizzi S; Bureau R; Sassier M; Rochais C; Alexandre J; Lelong-Boulouard V; Dolladille C; Dallemagne P
    Br J Clin Pharmacol; 2021 Jul; 87(7):2830-2837. PubMed ID: 33274491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced depressive symptoms: An update through the WHO pharmacovigilance database.
    Li J; Zelmat Y; Storck W; Laforgue EJ; Yrondi A; Balcerac A; Sommet A; Montastruc F
    J Affect Disord; 2024 Apr; 350():452-467. PubMed ID: 38244800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac failure in patients treated with azacitidine, a pyrimidine analogue: Case reports and disproportionality analyses in Vigibase.
    Perino J; Mottal N; Bohbot Y; Servant V; Berroneau A; Poustis P; Fenaux P; Laribi K; Charbonnier A; Bilion E; Calmettes C; Bégaud B; Pigneux A; Milpied N; Miremont-Salamé G; Théophile H; Dimicoli-Salazar S
    Br J Clin Pharmacol; 2020 May; 86(5):991-998. PubMed ID: 31912911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Checkpoint Inhibitors and Venous Thromboembolism: An Analysis of the WHO Pharmacovigilance Database.
    Allouchery M; Beuvon C; Pérault-Pochat MC; Roblot P; Puyade M; Martin M
    Clin Pharmacol Ther; 2022 Jul; 112(1):164-170. PubMed ID: 35426120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced hyperglycemia and diabetes.
    Heurtebize MA; Faillie JL
    Therapie; 2024; 79(2):221-238. PubMed ID: 37985310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems.
    Raschi E; Parisotto M; Forcesi E; La Placa M; Marchesini G; De Ponti F; Poluzzi E
    Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1098-1107. PubMed ID: 29174026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.